On Wednesday shares of Oclaro, Inc. (NASDAQ:OCLR) closed at $1.94. Company’s sales growth for last 5 years was 13.10% and EPS growth for next 5 years is recorded as 10.00%. Oclaro, Inc. (NASDAQ:OCLR), announced it has signed a sales representative agreement with SJ Associates, Inc., one of the largest groups of technical electronic component sales representatives in the North Eastern United States. The relationship will enable Oclaro to bring its entire portfolio of high-performance optical transceiver solutions for 10G, 25G, 40G, and 100G applications to an important geographic region with a broad range of telecom, enterprise and data center customers.
Enzymotec Ltd. (NASDAQ:ENZY) in last trading activity decreased -0.44% to close at $8.95. Company weekly performance is 0.34% while its quarterly performance stands at 36.02%. Enzymotec Ltd. (NASDAQ:ENZY) is -56.85% away from its 52 week high. On April 30, Enzymotec Ltd., (NASDAQ:ENZY), announced that the Company had positive results from a clinical trial comparing the effectiveness of Vayarol® versus Ethyl Esters of Omega 3 (“EE,” which are the active ingredients in a leading brand), for the management of moderate levels of triglycerides.
On last trading day RealNetworks Inc. (NASDAQ:RNWK) decreased -0.16% to close at $6.38. Its volatility for the week is 4.12% while volatility for the month is 2.54%. RNWK’s sales growth for past 5 years was -22.60% and its EPS growth for past 5 years was 21.10%. RealNetworks Inc. (NASDAQ:RNWK) monthly performance is -3.48%. RealNetworks, Inc. (NASDAQ:RNWK) announced results for the first quarter ended March 31, 2015. For the first quarter of 2015, revenue was $30.6 million, compared to $35.5 million in the previous quarter and $45.7 million in the first quarter of 2014.
GoPro, Inc. (NASDAQ:GPRO) has 10.40% insider ownership while its institutional ownership stands at 34.50%. In last trading activity company’s stock closed at $48.19. GoPro (NASDAQ:GPRO) was upgraded by Zacks from a “hold” rating to a “strong-buy” rating in a report issued on Monday. The firm currently has a $57.00 price objective on the stock.
On last trading day Coronado Biosciences, Inc. (NASDAQ:CNDO) remains unchanged to close at $3.44. Its volatility for the week is 8.61% while volatility for the month is 9.03%. CNDO’s EPS growth for past 5 years was -22.90%. Coronado Biosciences, Inc. (NASDAQ:CNDO) monthly performance is -9.47%. On April 27, Coronado Biosciences, Inc. (NASDAQ:CNDO) announced that it has changed its name to Fortress Biotech, Inc. The Company’s new NASDAQ stock ticker symbol is FBIO, which will be effective at the open of market on Tuesday, April 28, 2015.